Cellavision’s CEO Yvonne Mårtensson is leaving after 16 years at the company.
Yvonne Mårtensson remains CEO until a successor is appointed or until 31 December 2014 at the latest.
“I have had the privilege of being part of this exciting journey that started sixteen years ago. Together with fantastic colleagues I was able to take CellaVision from an invention and a few developers to an established medical technology company with 70 employees in Europe, North America and Asia. I am proud of having built a stable company with strong shared values, as a platform for continued development and growth,” says Yvonne Mårtensson who has been the company’s CEO since 1998.